Market Research Logo

Global Human Microbiome Therapeutics Market 2018-2022

Global Human Microbiome Therapeutics Market 2018-2022

About Human Microbiome Therapeutics

Microbiome Therapeutics is developing evidence-based microbiome modulators designed to shift bacterial populations and their environment in the gastrointestinal (GI) tract to better manage serious health conditions. GIT is an organ system that includes the mouth, esophagus, stomach, and the intestines. The GIT can be divided into upper Git and lower GIT. Upper GIT consists of the oral cavity, the pharynx, the esophagus, the stomach, and the duodenum. The lower GIT consists of the small and large intestines. Gastrointestinal disorders refer to diseases involving the GIT. Microbiome therapeutics are being increasingly adopted for the treatment of gastrointestinal disorders such as IBS and ulcerative colitis.

Technavio’s analysts forecast the global human microbiome therapeutics market to grow at a CAGR of 14.19% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global human microbiome therapeutics market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of human microbiome therapeutics.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Human Microbiome Therapeutics market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • ENTEROME Bioscience
  • Rebiotix
  • Seres Therapeutics
  • Vedanta Biosciences
Other prominent vendors
  • Bristol-Myers Squibb
  • Johnson & Johnson
  • Takeda Pharmaceutical
Market driver
  • Side effects of the existing treatments
  • For a full, detailed list, view our report
Market trend
  • Growing investments from venture capitalists
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Technavio Announces the Publication of its Research Report – Global Human Microbiome Therapeutics market 2018-2022

Technavio recognizes the following companies as the key players in the global human microbiome therapeutics market: ENTEROME Bioscience, Rebiotix, Seres Therapeutics, and Vedanta Biosciences.

Other Prominent Vendors in the market are: Bristol-Myers Squibb, Johnson & Johnson, and Takeda Pharmaceutical.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is growing investments from venture capitalists. Venture capitalists are capitalizing on the need for effective treatment and are offering therapeutic treatment solutions to treat disorders such as autoimmune disorders, infections, and cancer. Investments from venture capitalists towards microbiome therapeutics is exponentially boosting the growth of the microbiome sequencing therapeutics market. Vedanta Biosciences is already collaborating with NYU Langone Medical Center to develop novel microbiome- derived immunotherapies for cancer patients.”

According to the report, one of the major drivers for this market is side effects of the existing treatments. Various medicines available in the market have several side-effects including minor headaches. These medicines may also impart serious side-effects such as liver or kidney injury, heart problems, and even death. The seriousness of side-effects drives the need for innovative treatment technologies, such as human microbiome therapeutics, that have reduced the negative impact on the human body. The demand for microbiome therapeutics is increasing since it provides treatment sans chemicals.

Companies Mentioned

ENTEROME Bioscience, Rebiotix, Seres Therapeutics, Vedanta Biosciences, Bristol-Myers Squibb, Johnson & Johnson, and Takeda Pharmaceutical.

  • Executive summary
  • Scope of the report
  • Research methodology
  • Introduction
    • Market outline
      • Table Microbiome by host
      • Table Common prebiotics
      • Table Major sources of prebiotics
      • Table Benefits of probiotics
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global human microbiome therapeutics market: Characteristics
    • Market segmentation analysis
      • Table Global human microbiome therapeutics market: Segmentation
  • Market sizing
    • Market definition
      • Table Market definition: Inclusions and exclusions checklist
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast
      • Table Global human microbiome therapeutics market 2017-2022 ($ millions)
      • Table Global human microbiome therapeutics market: Year-over-year growth
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition: Five forces 2017
  • Pipelinelandscape
    • Table Pipeline landscape
    • Table Key clinical trials
  • Market segmentation by therapeutic application
    • Table Global human microbiome therapeutics market by therapeutic application 2017-2022 (% share)
    • Comparison by therapeutic application
      • Table Comparison by therapeutic application
    • Gastrointestinal disorders
      • Table Global human microbiome therapeutics market by gastrointestinal disorders 2017-2022 ($ millions)
      • Table Global human microbiome therapeutics market by gastrointestinal disorders: Year-overyear growth 2018-2022
    • Immunological conditions
      • Table Global human microbiome therapeutics market by immunological conditions 2017-2022 ($ millions)
      • Table Global human microbiome therapeutics market by immunological conditions: Year-overyear growth 2018-2022
    • Others
      • Table Global human microbiome therapeutics market by others 2017-2022 ($ millions)
      • Table Global human microbiome therapeutics market by others: Year-over-year growth 2018- 2022
    • Market opportunity by therapeutic application
      • Table Market opportunity by therapeutic application
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Table Global human microbiome therapeutics market by region 2017-2022 (% share)
    • Comparison by region
      • Table Regional comparison
    • Human microbiome therapeutics market in Americas
      • Table Human microbiome therapeutics market in Americas 2017-2022 ($ millions)
      • Table Human microbiome therapeutics market in Americas: Year-over-year growth
    • Human microbiome therapeutics market in EMEA
      • Table Human microbiome therapeutics market in EMEA 2017-2022 ($ millions)
      • Table Human microbiome therapeutics market in EMEA: Year-over-year growth 2018-2022
    • Human microbiome therapeutics market in APAC
      • Table Human microbiome therapeutics market in APAC 2017-2022 ($ millions)
      • Table Human microbiome therapeutics market in APAC: Year-over-year growth 2018-2022
      • Table Top Asian countries in terms of population with diabetes (millions)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity by region
      • Table Market opportunity by region
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Global obesity facts 2014
    • Market challenges
      • Table Factors causing changes in human microbiome
      • Table Antibiotic resistance steps
  • Market trends
    • Increase in industry-academia collaboration
    • Increasing investments by venture capitalists
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive analysis
      • Table Competitive structure analysis of global microbiome therapeutics market
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • ENTEROME Bioscience
      • Table ENTEROME Bioscience: Overview
      • Table ENTEROME Bioscience: Business segments
      • Table ENTEROME Bioscience: Organizational developments
      • Table ENTEROME Bioscience: Geographic focus
      • Table ENTEROME Bioscience: Segment focus
      • Table ENTEROME Bioscience: Key offerings
    • Rebiotix
      • Table Rebiotix: Overview
      • Table Rebiotix: Business segments
      • Table Rebiotix: Organizational developments
      • Table Rebiotix: Geographic focus
      • Table Rebiotix: Segment focus
      • Table Rebiotix: Key offerings
    • Seres Therapeutics
      • Table Seres Therapeutics: Overview
      • Table Seres Therapeutics: Business segments
      • Table Seres Therapeutics: Organizational developments
      • Table Seres Therapeutics: Geographic focus
      • Table Seres Therapeutics: Segment focus
      • Table Seres Therapeutics: Key offerings
    • Vedanta Biosciences
      • Table Vedanta Biosciences: Overview
      • Table Vedanta Biosciences: Business segments
      • Table Vedanta Biosciences: Organizational developments
      • Table Vedanta Biosciences: Geographic focus
      • Table Vedanta Biosciences: Segment focus
      • Table Vedanta Biosciences: Key offerings
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report